Our 25 KLD Pharmaceutical Effluent Treatment Plant (ETP) is an advanced, integrated wastewater treatment solution designed specifically for pharmaceutical industries, API manufacturing units, formulation plants, bulk drug manufacturers, chemical-pharmaceutical industries and other high-strength industrial wastewater generating facilities.
The system is designed to provide systematic treatment of pharmaceutical effluent through a combination of primary treatment, secondary biological treatment and tertiary treatment, followed by Reverse Osmosis (RO) and an electrically operated evaporation system. The treated and recovered water can be reused within the process, helping industries reduce freshwater consumption, wastewater discharge and overall water-management costs.
The complete treatment system is engineered according to the characteristics of pharmaceutical wastewater, including variations in COD, BOD, TDS, suspended solids, dissolved solids, colour, organic loading and other process-specific contaminants.
The 25 KLD ETP is designed for a treatment capacity of approximately 25,000 litres per day and can be configured according to the actual effluent characteristics and production process of the pharmaceutical manufacturing facility.
Pharmaceutical wastewater can contain a complex combination of biodegradable and non-biodegradable organic compounds, dissolved solids, chemicals, salts and process residues. Therefore, a conventional treatment system alone may not always be sufficient.
Our integrated treatment approach combines:
Effluent Collection → Equalization → Primary Treatment → Secondary Biological Treatment → Tertiary Treatment → RO System → Electric Evaporation → Water Recovery & Reuse
